Analysts Offer Insights on Technology Companies: UiPath (PATH), Nextpower Inc (NXT) and Braze (BRZE)
Analysts have been eager to weigh in on the Technology sector with new ratings on UiPath (PATH), Nextpower Inc (NXT) and Braze (BRZE).
Memorial Day Sale – Claim 70% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
UiPath (PATH)
In a report released today, Jason Celino from KeyBanc maintained a Hold rating on UiPath. The company’s shares closed last Thursday at $11.58, close to its 52-week low of $9.50.
According to TipRanks.com, Celino is a 2-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for UiPath with a $13.36 average price target, a 17.0% upside from current levels. In a report issued on May 15, RBC Capital also maintained a Hold rating on the stock with a $12.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Nextpower Inc (NXT)
In a report released today, Sophie Karp from KeyBanc maintained a Buy rating on Nextpower Inc. The company’s shares closed last Thursday at $137.17.
According to TipRanks.com, Karp is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Nextpower Inc with a $147.07 average price target, implying an 8.9% upside from current levels. In a report issued on May 14, Jefferies also maintained a Buy rating on the stock with a $145.00 price target.
Braze (BRZE)
In a report released today, Raimo Lenschow from Barclays maintained a Buy rating on Braze, with a price target of $31.00. The company’s shares closed last Thursday at $23.36.
According to TipRanks.com, Lenschow is a 4-star analyst with an average return of
Braze has an analyst consensus of Strong Buy, with a price target consensus of $34.88, a 54.2% upside from current levels. In a report issued on May 27, TipRanks – PerPlexity also upgraded the stock to Buy with a $28.00 price target.
Read More on PATH:
